SCHEMBL30289299

SCHEMBL30289299

Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(CN3CCN(C(=O)OC(C)(C)C)C(C(=O)OC(C)(C)C)C3)cc21

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 19/20 0.52
▸ DDB1 Q16531 18/20 0.52
▸ IKZF3 Q9UKT9 1/20 0.33
▸ IKZF1 Q13422 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30289499 0.93 CRBN (0.51) CRBNDDB1
SCHEMBL31217697 0.91 CRBN (0.54) CRBNDDB1IKZF3
SCHEMBL30289000 0.90 CRBN (0.48) CRBNDDB1
SCHEMBL30289100 0.87 CRBN (0.50) CRBNDDB1
SCHEMBL30289153 0.87 CRBN (0.51) CRBNDDB1
SCHEMBL30289502 0.87 CRBN (0.51) CRBNDDB1
SCHEMBL30289409 0.87 DDB1 (0.44) CRBNDDB1IKZF1
SCHEMBL21997585 0.86 CRBN (0.58) CRBNDDB1IKZF3
SCHEMBL30289241 0.86 CRBN (0.50) CRBNDDB1
SCHEMBL30289322 0.86 CRBN (0.50) CRBNDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405359-A2 MDM2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-07-31 — — EP disclosed
WO-2023049790-A2 MDM2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-03-30 — — WO disclosed
Send feedback